Workshop: Computational Modelling of Cancer Biology and Treatments

About SMB Forums Conferences Workshop: Computational Modelling of Cancer Biology and Treatments

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
  • #6800

    Dear colleagues,

    We would like to invite you to attend a free 3-day virtual workshop on Computational Modelling of Cancer Biology and Treatments, supported by the Centre de recherches mathématiques (CRM), on July 19th – 21st. This workshop will focus on computational modelling techniques (agent-based modelling, in silico clinical trials and data fitting) in cancer with the following themes:

    Day 1: developing models in oncology and incorporating experimental/clinical data
    Day 2: developing ABM models in cancer research
    Day 3: developing complex models and using virtual patients to predict treatment outcomes

    Registration for the event is available at our website, and a full program/information on the virtual meeting links will be provided closer to the date. Below is a list of the fantastic speakers that will be presenting:

    Dr Richard Allen, Pfizer
    Dr Morgan Craig, Sainte-Justine University Hospital Research Centre/Université de Montréal
    Dr Tyler Cassidy, Los Alamos National Laboratory
    Dr Lisette de Pillis, Harvey Mudd College
    Dr Heiko Enderling, Moffit Cancer Centre
    Dr Stacey Finley, University of California San Francisco
    Dr Jill Gallaher, Moffitt Cancer Centre
    Dr Thomas Hillen, University of Alberta
    Dr Adrianne Jenner, Queensland University of Technology
    Dr Paul Macklin, Indiana University
    Dr Cicely Macnamara, University of St Andrews
    Dr David Dai, Pfizer
    Dr Anudeep Surendran, Université de Montréal/CRM

    Please share the workshop information widely within your networks and we look forward to welcoming you (virtually) to the Computational Modelling of Cancer Biology and Treatments workshop.

    Thank you,

    Adrianne Jenner and Morgan Craig


Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.

Comments are closed.